Octapharma is investing $1.5 billion to build a new massive complex, including manufacturing capabilities, in South Carolina, according to the Charlotte Business Journal. The Swiss company, which develops and manufactures medicines for hematology, immunotherapy and critical care, is behind an effort labeled “Project Palmetto Rock,” the report says. It states that York County Council held a meeting…
